3,4-methylenedioxyamphetamine has been researched along with scopolamine hydrobromide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Callaway, CW; Geyer, MA; Rempel, NL | 1 |
Hatzidimitriou, G; Markowska, AL; Olton, DS; Ricaurte, GA; Wenk, GL; Wlos, J | 1 |
2 other study(ies) available for 3,4-methylenedioxyamphetamine and scopolamine hydrobromide
Article | Year |
---|---|
Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Caffeine; Designer Drugs; Dopamine Agents; Dose-Response Relationship, Drug; Fluoxetine; Indoles; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Receptor Agonists; Synapses | 1993 |
3,4-Methylenedioxymethamphetamine, serotonin and memory.
Topics: 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Brain Chemistry; Desipramine; Immunohistochemistry; Learning; Male; Memory; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Scopolamine; Serotonin | 1993 |